By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


RXi Pharmaceuticals 

1500 West Park Drive
Suite 210
Westborough  Massachusetts  01581  U.S.A.
Phone: 508-767-3861 Fax: 508-767-3862


Company News
RXi Pharmaceuticals (RXII) Expands Clinical Program With Initiation Of Third Phase 2a Study With RXI-109 For Treatment Of Hypertrophic Scars 7/30/2014 8:06:51 AM
RXi Pharmaceuticals (RXII) Appoints Peter Campochiaro M.D. To Its Scientific Advisory Board 7/7/2014 9:41:29 AM
Thriving RXi Pharmaceuticals (RXII) Opens New Office And Laboratory In Massachusetts 7/2/2014 6:12:57 AM
RXi Pharmaceuticals (RXII) Set To Join Russell Microcap Index 6/25/2014 6:39:22 AM
RXi Pharmaceuticals (RXII) To Present At The Jefferies and Co. 2014 Global Healthcare Conference 5/27/2014 6:20:22 AM
RXi Pharmaceuticals (RXII) Granted U.S. Notice Of Allowance Covering Self-Delivering (Sd-Rxrna) Technology Platform 5/22/2014 9:30:22 AM
RXi Pharmaceuticals (RXII) Reports Financial Results For The First Quarter Of 2014 5/14/2014 6:39:25 AM
RXi Pharmaceuticals (RXII) Announces Positive Results With RXI?109 In The Eyes Of Cynomolgus Monkeys As Part Of A Dose Range Finding Study 5/2/2014 9:05:59 AM
RXi Pharmaceuticals (RXII) Announces Initiation Of Phase 2a Keloid Study 4/29/2014 11:22:30 AM
RXi Pharmaceuticals (RXII) To Present At Association for Research in Vision & Ophthalmology 2014 Annual Meeting 4/28/2014 8:28:31 AM